Use este identificador para citar ou linkar para este item: http://repositorio.ufc.br/handle/riufc/53476
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorOliveira, Ana P. A.-
dc.contributor.authorFreitas, Jennifer T. J.-
dc.contributor.authorDiniz, Renata-
dc.contributor.authorPessoa, Claudia-
dc.contributor.authorMaranhão, Sarah S.-
dc.contributor.authorRibeiro, Juliana M.-
dc.contributor.authorSouza-Fagundes, Elaine M.-
dc.contributor.authorBeraldo, Heloisa-
dc.date.accessioned2020-08-17T21:25:18Z-
dc.date.available2020-08-17T21:25:18Z-
dc.date.issued2020-02-
dc.identifier.citationOLIVEIRA, Ana P. A. et al. Triethylphosphinegold(I) complexes with secnidazole-derived thiosemicarbazones: cytotoxi activity against HCT-116 colorectal cancer cells under hypoxia conditions. ACS Omega, v. 5, n. 6, p. 2939−2946, feb. 2020.pt_BR
dc.identifier.urihttp://www.repositorio.ufc.br/handle/riufc/53476-
dc.description.abstractTriethylphosphinegold(I) complexes [Au(HL1)P(CH2CH3)3]PF6 (1), [Au(HL2)P(CH2CH3)3]PF6 (2), and [Au(HL3)P(CH2CH3)3]PF6 (3) were obtained with (E)-2-(1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ylidene)hydrazinecarbothioamide (HL1), (E)-N-methyl-2-(1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ylidene)hydrazinecarbothioamide (HL2), and (E)-2-(1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ylidene)-N-phenylhydrazinecarbothioamide (HL3). All compounds were assayed for their cytotoxic activities against HCT-116 colorectal carcinoma cells under normoxia and hypoxia conditions and against nonmalignant HEK-293 human embryonic kidney cells under normoxia conditions. The thiosemicarbazone ligands HL1-HL3 were inactive against HCT-116 cells under hypoxia but while HL3 was inactive, HL1 and HL2 proved to be cytotoxic to both cell lineages under normoxia conditions. Complexes (1-3) and the triethylphosphinegod(I) precursor proved to be active against both cell lineages in normoxia as well as in hypoxia. While 1 and 3 revealed to be active against HEK-293 and HCT-116 cells, being approximately as active against HCT-116 cells in normoxia as under hypoxia, complex (2) proved to be more active against HCT-116 cells under hypoxia than under normoxia conditions, and more active against HCT-116 cells than against the nonmalignant HEK-293 cells, with the selectivity index, calculated as SI = IC50HEK-293/IC50HCT-116hypoxia, equal to 3.7, similar to the value obtained for the control drug tirapazamine (tirapazamine (TPZ), SI = 4). Although the compounds showed distinct cytotoxic activities, the electrochemical behaviors of HL1-HL3 were very similar, as were the behaviors of complexes (1-3). Complex (2) deserves special interest since it was significantly more active under hypoxia than under normoxia conditions. Hence, in this case, selective reduction of the nitro group in a low oxygen pressure environment, resulting in toxic reactive oxygen species (ROS) and damage to DNA or other biomolecules, might operate, while for the remaining compounds, other modes of action probably occur.pt_BR
dc.language.isoenpt_BR
dc.publisherACS Omegapt_BR
dc.subjectHipóxiapt_BR
dc.subjectNeoplasiaspt_BR
dc.subjectNeoplasmspt_BR
dc.titleTriethylphosphinegold(I) complexes with secnidazole-derived thiosemicarbazones: cytotoxi activity against HCT-116 colorectal cancer cells under hypoxia conditionspt_BR
dc.typeArtigo de Periódicopt_BR
Aparece nas coleções:DFIFA - Artigos publicados em revista científica

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2020_art_apaoliveira.pdf1,85 MBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.